CVE-2023-38219

Validate Your Inputs | Cross-site Scripting (Stored XSS) (CWE-79) - Customer to Admin stored XSS with Gift wrapping

Description

Adobe Commerce versions 2.4.7-beta1 (and earlier), 2.4.6-p2 (and earlier), 2.4.5-p4 (and earlier) and 2.4.4-p5 (and earlier) are affected by a stored Cross-Site Scripting (XSS) vulnerability that could be abused by a low-privileged attacker to inject malicious scripts into vulnerable form fields. Malicious JavaScript may be executed in a victim’s browser when they browse to the page containing the vulnerable field. Payload is stored in an admin area, resulting in high confidentiality and integrity impact.

Category

8.7
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.83% Top 30%
Vendor Advisory adobe.com
Affected: Adobe Adobe Commerce
Published at:
Updated at:

References

Link Tags
https://helpx.adobe.com/security/products/magento/apsb23-50.html vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-38219?
CVE-2023-38219 has been scored as a high severity vulnerability.
How to fix CVE-2023-38219?
To fix CVE-2023-38219, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-38219 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-38219 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-38219?
CVE-2023-38219 affects Adobe Adobe Commerce.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.